Kennedy Capital Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Buy |
257,816
+52,716
| +26% | +$600K | 0.07% | 379 |
|
|
2025
Q1 | $2.44M | Buy |
205,100
+90,477
| +79% | +$1.07M | 0.06% | 407 |
|
|
2024
Q4 | $2.16M | Buy |
114,623
+785
| +0.7% | +$14.8K | 0.05% | 499 |
|
|
2024
Q3 | $2.56M | Buy |
113,838
+53,985
| +90% | +$1.21M | 0.06% | 469 |
|
|
2024
Q2 | $1.25M | Sell |
59,853
-28,407
| -32% | -$593K | 0.03% | 570 |
|
|
2024
Q1 | $1.3M | Sell |
88,260
-72,751
| -45% | -$1.07M | 0.03% | 596 |
|
|
2023
Q4 | $1.66M | Sell |
161,011
-2,612
| -2% | -$27K | 0.04% | 522 |
|
|
2023
Q3 | $1.29M | Buy |
163,623
+107,719
| +193% | +$847K | 0.03% | 541 |
|
|
2023
Q2 | $558K | Buy |
+55,904
| New | +$558K | 0.01% | 599 |
|